To maximize assay versatility, we incorporated the IFNγ-IFNγR JAK-STAT GAS-Luc2 reporting system in the cancer cells so users can employ multiple kinds of primary human immune cells for the counterpart of the cancer cells in the full human co-culture assay. This evidence concerns the gene IFNGR1 and cancer.